These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 21093937

  • 1. MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: a prospective validation study.
    Vazquez M, Jockers K, Christ-Crain M, Zimmerli W, Müller B, Schuetz P.
    Int J Cardiol; 2012 Apr 05; 156(1):16-23. PubMed ID: 21093937
    [Abstract] [Full Text] [Related]

  • 2. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.
    Krüger S, Ewig S, Kunde J, Hartmann O, Suttorp N, Welte T, CAPNETZ Study Group.
    Thorax; 2010 Mar 05; 65(3):208-14. PubMed ID: 20335288
    [Abstract] [Full Text] [Related]

  • 3. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections.
    Müller B, Süess E, Schuetz P, Müller C, Bingisser R, Bergmann A, Stolz D, Tamm M, Morgenthaler NG, Christ-Crain M.
    J Intern Med; 2006 Dec 05; 260(6):568-76. PubMed ID: 17116008
    [Abstract] [Full Text] [Related]

  • 4. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 5. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia.
    Nowak A, Breidthardt T, Christ-Crain M, Bingisser R, Meune C, Tanglay Y, Heinisch C, Reiter M, Drexler B, Arenja N, Twerenbold R, Stolz D, Tamm M, Müller B, Müller C.
    Chest; 2012 Apr 13; 141(4):974-982. PubMed ID: 22135381
    [Abstract] [Full Text] [Related]

  • 6. Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in patients with community-acquired pneumonia: results from the german competence network CAPNETZ.
    Krüger S, Ewig S, Giersdorf S, Hartmann O, Frechen D, Rohde G, Suttorp N, Welte T, CAPNETZ study group.
    Respir Med; 2014 Nov 13; 108(11):1696-705. PubMed ID: 25306251
    [Abstract] [Full Text] [Related]

  • 7. Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia.
    Prat C, Lacoma A, Dominguez J, Papassotiriou J, Morgenthaler NG, Andreo F, Tudela P, Ruiz-Manzano J, Ausina V.
    J Infect; 2007 Nov 13; 55(5):400-7. PubMed ID: 17825918
    [Abstract] [Full Text] [Related]

  • 8. Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease.
    von Haehling S, Papassotiriou J, Hartmann O, Doehner W, Stellos K, Geisler T, Wurster T, Schuster A, Botnar RM, Gawaz M, Bigalke B.
    Clin Sci (Lond); 2012 Nov 13; 123(10):601-10. PubMed ID: 22690794
    [Abstract] [Full Text] [Related]

  • 9. Bacteremia and MR-proANP changes in mild community-acquired pneumonia.
    Guinard-Barbier S, Chenevier-Gobeaux C, Grabar S, Quinquis L, Schmidt J, Hausfater P, Casalino E, Huet S, Pourriat JL, Renaud B, Claessens YE.
    Biomarkers; 2011 Dec 13; 16(8):637-41. PubMed ID: 22103585
    [Abstract] [Full Text] [Related]

  • 10. Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke.
    Katan M, Fluri F, Schuetz P, Morgenthaler NG, Zweifel C, Bingisser R, Kappos L, Steck A, Engelter ST, Müller B, Christ-Crain M.
    J Am Coll Cardiol; 2010 Sep 21; 56(13):1045-53. PubMed ID: 20846604
    [Abstract] [Full Text] [Related]

  • 11. Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia.
    Masiá M, Papassotiriou J, Morgenthaler NG, Hernández I, Shum C, Gutiérrez F.
    Clin Chem; 2007 Dec 21; 53(12):2193-201. PubMed ID: 17951293
    [Abstract] [Full Text] [Related]

  • 12. Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD.
    Bernasconi M, Tamm M, Bingisser R, Miedinger D, Leuppi J, Müller B, Christ-Crain M, Stolz D.
    Chest; 2011 Jul 21; 140(1):91-99. PubMed ID: 21106656
    [Abstract] [Full Text] [Related]

  • 13. Midregional pro-A-type natriuretic peptide for diagnosis and prognosis in patients with suspected acute myocardial infarction.
    Meune C, Twerenbold R, Drexler B, Balmelli C, Wolf C, Haaf P, Reichlin T, Irfan A, Reiter M, Zellweger C, Meissner J, Stelzig C, Freese M, Capodarve I, Mueller C.
    Am J Cardiol; 2012 Apr 15; 109(8):1117-23. PubMed ID: 22257708
    [Abstract] [Full Text] [Related]

  • 14. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A, Struck J, Dieplinger B, Poelz W, Pacher R, Morgenthaler NG, Bergmann A, Haltmayer M, Mueller T.
    J Card Fail; 2007 Feb 15; 13(1):42-9. PubMed ID: 17339002
    [Abstract] [Full Text] [Related]

  • 15. Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study.
    Daniels LB, Clopton P, Potocki M, Mueller C, McCord J, Richards M, Hartmann O, Anand IS, Wu AH, Nowak R, Peacock WF, Ponikowski P, Mockel M, Hogan C, Filippatos GS, Di Somma S, Ng L, Neath SX, Christenson R, Morgenthaler NG, Anker SD, Maisel AS.
    Eur J Heart Fail; 2012 Jan 15; 14(1):22-31. PubMed ID: 22140234
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.
    Krüger S, Ewig S, Giersdorf S, Hartmann O, Suttorp N, Welte T, German Competence Network for the Study of Community Acquired Pneumonia (CAPNETZ) Study Group.
    Am J Respir Crit Care Med; 2010 Dec 01; 182(11):1426-34. PubMed ID: 20639437
    [Abstract] [Full Text] [Related]

  • 17. Admission D-dimer can identify low-risk patients with community-acquired pneumonia.
    Chalmers JD, Singanayagam A, Scally C, Hill AT.
    Ann Emerg Med; 2009 May 01; 53(5):633-8. PubMed ID: 19201061
    [Abstract] [Full Text] [Related]

  • 18. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD.
    J Am Coll Cardiol; 2010 May 11; 55(19):2062-76. PubMed ID: 20447528
    [Abstract] [Full Text] [Related]

  • 19. The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke.
    Fischer M, Katan M, Morgenthaler NG, Seiler M, Müller B, Lackner P, Errath M, Helbok R, Pfausler B, Beer R, Schmutzhard E, Broessner G.
    Cerebrovasc Dis; 2014 May 11; 37(2):128-33. PubMed ID: 24481415
    [Abstract] [Full Text] [Related]

  • 20. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M.
    Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.